Loading
Hill-Rom Holdings, Inc. Stock: price and insider trades · United States
Hill-Rom Holdings, Inc.: what insiders have been doing
This page follows insider dealings at Hill-Rom Holdings, Inc. as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. Hill-Rom Holdings, Inc. has had no insider filing for more than a year; the last one goes back to 15 December 2021.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
41
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€1M
15 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2021FY ended September 2021 · cache
Income statement
RevenueUS$2.6B
Gross profitUS$1.2B47% margin
Net incomeUS$214M8.2% margin
Last declaration on 15 December 2021
Declarations41 total
16,539 sharesCommon StockSEC:0001214659-21-013226:0
5,376 sharesCommon StockSEC:0001214659-21-013221:0
2,284 sharesCommon StockSEC:0001214659-21-013222:0
3,903.066 sharesCommon StockSEC:0001214659-21-013215:0
13,566 sharesCommon StockSEC:0001214659-21-013213:0
300 sharesCommon StockSEC:0001214659-21-013212:0
5,692.577 sharesCommon StockSEC:0001214659-21-013218:0
26,527 sharesCommon StockSEC:0001214659-21-013216:0
14,039.759 sharesCommon StockSEC:0001214659-21-013211:0
2,000 sharesCommon StockSEC:0001214659-21-013224:0
34,870 sharesCommon StockSEC:0001214659-21-013225:0
5,300 shares0Common StockSEC:0001214659-21-012903:0
992 sharesCommon StockSEC:0001214659-21-012902:0
16,895 shares0Common StockSEC:0001214659-21-011984:0
840 sharesCommon StockSEC:0001214659-21-011925:0
1,115 sharesCommon StockSEC:0001214659-21-011927:0
825 sharesCommon StockSEC:0001214659-21-011924:0
1,557 sharesCommon StockSEC:0001214659-21-011929:0
700 sharesCommon StockSEC:0001214659-21-011930:0
1,634 sharesCommon StockSEC:0001214659-21-011928:0
5,193 sharesCommon StockSEC:0001214659-21-011933:0
1,109 sharesCommon StockSEC:0001214659-21-011926:0
2,018 shares@ US$94.1414.4% of flowCommon StockSEC:0001214659-21-011621:0
4,114 sharesCommon StockSEC:0001214659-21-011440:0
644 sharesCommon StockSEC:0001214659-21-011439:0
25 of 41 declarations
About Hill-Rom Holdings, Inc.
Hill-Rom Holdings, Inc. was a U.S.-based medical technology company listed on the NYSE under the ticker HRC. It was incorporated in 1969 in Indiana and was headquartered in Chicago, Illinois, United States. Historically, Hill-Rom built its reputation as a provider of hospital equipment and connected care solutions, serving acute-care hospitals, post-acute settings, and home-care environments. Its brand was particularly associated with hospital beds, therapeutic support surfaces, fall and pressure-injury prevention systems, continuous patient monitoring, respiratory care devices, and related clinical workflow solutions. ([sec.gov](https://www.sec.gov/Archives/edgar/data/47518/000004751817000130/a2017q410k.htm?utm_source=openai))
From a business-model perspective, Hill-Rom operated across complementary product and service lines centered on patient support, front-line care, and respiratory/home-care therapies. That mix gave the company exposure to both capital equipment and recurring clinical needs. Its competitive position was supported by an established installed base, long-standing customer relationships with healthcare providers, and a strong focus on technologies designed to improve patient safety, detect deterioration earlier, and reduce avoidable complications in clinical settings. ([hillrom.com](https://www.hillrom.com/en/products/centrella-smart-bed/?utm_source=openai))
Read moreShow less
Geographically, Hill-Rom had a meaningful U.S. footprint and also operated internationally. In its 2020 SEC filing, the company reported approximately 10,000 employees worldwide, with about 6,000 in the United States and about 4,000 outside the United States, underscoring that it was a domestically anchored company with global reach. ([sec.gov](https://www.sec.gov/Archives/edgar/data/47518/000004751820000129/hrc-20200930.htm?utm_source=openai))
The most important recent development was Baxter International’s acquisition of Hillrom. Baxter announced the transaction in September 2021 and completed it on December 13, 2021. Baxter described the deal as a way to expand connected-care capabilities, broaden access across the hospital, home, and alternate-site continuum, and accelerate innovation and international expansion. As a result, Hill-Rom ceased to exist as an independent publicly traded company, so historical SEC filings—including insider Form 4 transactions—should be interpreted in that context. For investors, this means Hill-Rom is best viewed as a legacy medtech franchise now embedded in Baxter rather than an active standalone listed issuer. ([baxter.com](https://www.baxter.com/baxter-newsroom/baxter-acquire-hillrom-expanding-connected-care-and-medical-innovation-globally?utm_source=openai))
